We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Flightstore | LSE:FLS | London | Ordinary Share | GB00B2423515 | ORD 0.25P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.50 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 1.50 | GBX |
Flightstore (FLS) Share Charts1 Year Flightstore Chart |
|
1 Month Flightstore Chart |
Intraday Flightstore Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 27/9/2007 | 08:33 | vphase .......... voltage control technology | 3 |
| 26/4/2005 | 17:38 | Finsbury Life Sciences | 4 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 26/4/2005 17:38 by damanko PRESS ANNOUNCEMENTFINSBURY LIFE SCIENCES INVESTMENT TRUST PLC ("FLS" or the "Company") Posting of circular to shareholders seeking approval for a change in investment objective and policy and the investment management arrangements, release of obligation to put forward a continuation vote in 2005, a proposed change of name, amendment of the Articles of Association and renewal of buy back authority On 7 April 2005 the Board of FLS announced that it would be writing to shareholders seeking approval for proposals to change the investment objective and policy of the Company so as to widen the geographic exposure and to change the nature of the companies in which FLS invests. In order to manage the Company's investment portfolio under this broadened investment remit the Board proposes to appoint OrbiMed Capital LLC in place of the Company's existing investment advisers. The Board is also proposing to change the Company's name to Finsbury Emerging Biotechnology Trust PLC, which more closely reflects its new objective and to implement an active discount management policy. A circular detailing the proposals and convening an Extraordinary General Meeting for 19 May 2005 to implement the proposals has been sent to shareholders today, 26 April 2005. |
Posted at 13/4/2005 17:49 by damanko Thanks Ram. Though he clearly has a fan club, I reckon institutions have bought 15% plus of the issued share capital in the past couple of weeks, and with a stock like this, they will be in for the longer term. Add to that the pretty huge share buyback last week, and all this bodes well for FLS in the medium term.Onwards and........... |
Posted at 11/4/2005 09:45 by damanko Anyone have an idea what is going on at this little biotech investment trust? Recent RNS's show very large volumes bought by institutions, as well as hefty share buybacks for cancelling. Possible a buy note has been issued? Massive amount of activity for such a small trust, more than I've witnessed over the past couple of years in such a short space of time.Also possible that one of the investee companies has something in the pipeline that the market in general is not aware of. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
